NiTi's proprietary technology represents a breakthrough in natural healing with tissue-sparing, uniform BioDynamix™ Anastomosis. The company’s unique line of products utilizes Nitinol-based elements to press together the ends of resected tissue, enabling a natural reconnection of the intestine after removing a section, for example, as part of a colon cancer treatment.
The company is commercializing a family of FDA-cleared and CE-marked disposable tissue closure devices.
We are very interested in your opinion. Ask about and discuss NiTi's technology and products, as well as related clinical issues with our experts by This e-mail address is being protected from spambots. You need JavaScript enabled to view it or using a contact form.
Read more about relevant clinical trials.
ACDS
23rd Annual International Colorectal Disease Symposium
February 15-18, 2012
Fort Lauderdale, Florida, USA
ASCRS Annual Meeting
June 2-6, 2012
San Antonio, TX, USA
www.fascrs.org